应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
FLGT Fulgent Genetics Inc.
盘后交易 12-05 17:37:23 EST
27.79
-0.51
-1.80%
盘后
27.79
+0.00
0.00%
17:01 EST
最高
28.57
最低
27.70
成交量
21.15万
今开
28.42
昨收
28.30
日振幅
3.07%
总市值
8.59亿
流通市值
5.18亿
总股本
3,091万
成交额
589.43万
换手率
1.13%
流通股本
1,864万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Fulgent Genetics第三季度收入为8406.9万美元
投资观察 · 11-20
Fulgent Genetics第三季度收入为8406.9万美元
Fulgent Genetics, Inc.盘中异动 股价大涨5.04%
市场透视 · 11-11
Fulgent Genetics, Inc.盘中异动 股价大涨5.04%
异动解读 | Fulgent Genetics盘中大涨19.81%,上调全年营收预期且三季度业绩超预期
异动解读 · 11-07
异动解读 | Fulgent Genetics盘中大涨19.81%,上调全年营收预期且三季度业绩超预期
异动解读 | 富尔金特基因公司盘前大涨9.20%,上调全年营收预期且三季度业绩超预期
异动解读 · 11-07
异动解读 | 富尔金特基因公司盘前大涨9.20%,上调全年营收预期且三季度业绩超预期
Fulgent Genetics, Inc.2025财年第二财季实现净利润-18.96百万美元,同比减少117.68%
市场透视 · 08-10
Fulgent Genetics, Inc.2025财年第二财季实现净利润-18.96百万美元,同比减少117.68%
Fulgent Genetics, Inc.盘中异动 股价大跌5.08%
市场透视 · 08-08
Fulgent Genetics, Inc.盘中异动 股价大跌5.08%
异动解读 | Fulgent Genetics盘前大涨10.59%,第二季度毛利润超3400万美元
异动解读 · 08-01
异动解读 | Fulgent Genetics盘前大涨10.59%,第二季度毛利润超3400万美元
Fulgent Genetics, Inc.盘中异动 临近收盘股价大跌5.07%报18.15美元
市场透视 · 07-16
Fulgent Genetics, Inc.盘中异动 临近收盘股价大跌5.07%报18.15美元
加载更多
公司概况
公司名称:
Fulgent Genetics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Fulgent Genetics, Inc.在2016年5月13日注册成立于美国特拉华州。该公司是一家以技术为基础的公司,拥有成熟的临床诊断业务和治疗开发业务。该公司临床诊断业务提供分子诊断检测服务、全面的基因检测和高质量的解剖病理实验室服务,旨在为医生和患者提供临床可操作的诊断信息,以提高患者护理质量。该公司的治疗开发业务专注于使用新型纳米封装和靶向治疗平台开发治疗多种癌症的候选药物,该平台旨在改善新的和现有癌症药物的治疗窗口和药代动力学特征,或PK特征。该公司的目标是从基因组诊断业务转型为一家完全整合的精准医疗公司。
发行价格:
--
{"stockData":{"symbol":"FLGT","market":"US","secType":"STK","nameCN":"Fulgent Genetics Inc.","latestPrice":27.79,"timestamp":1764968400000,"preClose":28.3,"halted":0,"volume":211528,"hourTrading":{"tag":"盘后","latestPrice":27.79,"preClose":27.79,"latestTime":"17:01 EST","volume":10502,"amount":291850.74803200003,"timestamp":1764972072838},"delay":0,"floatShares":18644945,"shares":30912392,"eps":-1.40324,"marketStatus":"盘后交易","change":-0.51,"latestTime":"12-05 17:37:23 EST","open":28.42,"high":28.57,"low":27.7,"amount":5894325.234408,"amplitude":0.030742,"askPrice":28.25,"askSize":20,"bidPrice":27.25,"bidSize":73,"shortable":3,"etf":0,"ttmEps":-1.40324,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1764982800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1475121600000,"exchange":"NASDAQ","adjPreClose":28.3,"postHourTrading":{"tag":"盘后","latestPrice":27.79,"preClose":27.79,"latestTime":"17:01 EST","volume":10502,"amount":291850.74803200003,"timestamp":1764972072838},"volumeRatio":1.202011,"impliedVol":0.4584,"impliedVolPercentile":0.356},"requestUrl":"/m/hq/s/FLGT","defaultTab":"news","newsList":[{"id":"1154327299","title":"Fulgent Genetics第三季度收入为8406.9万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154327299","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154327299?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:10","pubTimestamp":1763572212,"startTime":"0","endTime":"0","summary":"11月7日报道 - Fulgent Genetics第三季度营业收入为-1535万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLGT","BK4196"],"gpt_icon":0},{"id":"2582348385","title":"Fulgent Genetics, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582348385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582348385?lang=zh_cn&edition=full","pubTime":"2025-11-11 23:20","pubTimestamp":1762874408,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日23时20分,Fulgent Genetics, Inc.股票出现异动,股价快速拉升5.04%。Fulgent Genetics, Inc.股票所在的生命科学行业中,整体涨幅为1.19%。Fulgent Genetics, Inc.公司简介:Fulgent Genetics Inc 是一家专注于基因检测的技术公司,为医生提供临床可操作的诊断信息。消息层面,截至23时20分,《派杰投资维持Fulgent Genetics持有评级,上调目标价至30美元》资讯为影响Fulgent Genetics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111232008a6f24fb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111232008a6f24fb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FLGT","BK4196"],"gpt_icon":0},{"id":"1188364264","title":"异动解读 | Fulgent Genetics盘中大涨19.81%,上调全年营收预期且三季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1188364264","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188364264?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:48","pubTimestamp":1762526908,"startTime":"0","endTime":"0","summary":"基因检测公司Fulgent Genetics今日盘中大涨19.81%,引发市场广泛关注。该公司股价的强劲表现主要源于其最新发布的财务预期调整和亮眼的季度业绩报告。富尔金特基因宣布上调2025财年的营收预期至3.25亿美元,高于此前预期的3.2亿美元。值得注意的是,富尔金特基因的股价在此次上涨前已经累计上涨20.8%。此次盘中大涨进一步凸显了市场对公司未来发展前景的乐观态度。随着基因检测技术在医疗健康领域的应用不断扩大,富尔金特基因有望继续受益于行业增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["FLGT"],"gpt_icon":0},{"id":"1186239035","title":"异动解读 | 富尔金特基因公司盘前大涨9.20%,上调全年营收预期且三季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1186239035","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186239035?lang=zh_cn&edition=full","pubTime":"2025-11-07 21:34","pubTimestamp":1762522463,"startTime":"0","endTime":"0","summary":"基因检测公司富尔金特基因今日盘前大涨9.20%,引发市场关注。该公司股价的强劲表现主要源于其最新发布的财务预期和季度业绩报告。富尔金特基因宣布上调2025财年的营收预期至3.25亿美元,高于此前预期的3.2亿美元。同时,公司公布的第三季度营收为8407万美元,远超市场预期的8140万美元。值得注意的是,富尔金特基因的股价在此次上涨前已经累计上涨20.8%。随着基因检测技术在医疗健康领域的应用不断扩大,富尔金特基因有望继续受益于行业增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["FLGT"],"gpt_icon":0},{"id":"2558502222","title":"Fulgent Genetics, Inc.2025财年第二财季实现净利润-18.96百万美元,同比减少117.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558502222","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558502222?lang=zh_cn&edition=full","pubTime":"2025-08-10 00:01","pubTimestamp":1754755282,"startTime":"0","endTime":"0","summary":"8月10日,Fulgent Genetics, Inc.公布财报,公告显示公司2025财年第二财季净利润为-18.96百万美元,同比减少117.68%;其中营业收入为81.80百万美元,同比增加15.16%,每股基本收益为-0.62美元。从资产负债表来看,Fulgent Genetics, Inc.总负债88.20百万美元,其中短期债务2.02百万美元,资产负债比为0.14,流动比率为0.07。机构评级:截至2025年8月10日,当前有3家机构对Fulgent Genetics, Inc.目标价做出预测,其中目标均价为25.33美元,其中最低目标价为21.00美元,最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000256a47efbff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000256a47efbff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FLGT"],"gpt_icon":0},{"id":"2557659349","title":"Fulgent Genetics, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557659349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557659349?lang=zh_cn&edition=full","pubTime":"2025-08-08 02:41","pubTimestamp":1754592068,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日02时41分,Fulgent Genetics, Inc.股票出现波动,股价大幅下挫5.08%。Fulgent Genetics, Inc.股票所在的生命科学行业中,整体涨幅为1.14%。其相关个股中,Advanced Biomed Inc.、Veracyte, Inc.、Biodesix, Inc.涨幅较大,Advanced Biomed Inc.、Applied Dna Sciences, Inc.、精密科学较为活跃,换手率分别为52.59%、9.49%、7.43%,振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Advanced Biomed Inc.、燃石医学,振幅分别为51.36%、46.10%、22.46%。Fulgent Genetics, Inc.公司简介:Fulgent Genetics Inc 是一家专注于基因检测的技术公司,为医生提供临床可操作的诊断信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808024108a47b8372&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808024108a47b8372&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","BK4198","ADVB","FLGT"],"gpt_icon":0},{"id":"1162835761","title":"异动解读 | Fulgent Genetics盘前大涨10.59%,第二季度毛利润超3400万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162835761","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162835761?lang=zh_cn&edition=full","pubTime":"2025-08-01 19:06","pubTimestamp":1754046397,"startTime":"0","endTime":"0","summary":"基因检测公司Fulgent Genetics Inc.今日盘前股价大涨10.59%,引起市场广泛关注。根据公司最新发布的财报显示,Fulgent Genetics在第二季度实现毛利润3443.5万美元。虽然公司尚未公布完整的财务报告,但这个毛利润数据已经给市场传递了积极信号。分析人士指出,这可能反映了Fulgent Genetics在基因检测市场的竞争力正在增强,或者公司的成本控制措施取得了成效。然而,投资者仍需等待公司发布更多财务细节,以全面评估Fulgent Genetics的经营状况和未来前景。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["FLGT"],"gpt_icon":0},{"id":"2551419476","title":"Fulgent Genetics, Inc.盘中异动 临近收盘股价大跌5.07%报18.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551419476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551419476?lang=zh_cn&edition=full","pubTime":"2025-07-16 03:52","pubTimestamp":1752609152,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日03时52分,Fulgent Genetics, Inc.股票出现异动,股价急速下挫5.07%。截至发稿,该股报18.15美元/股,成交量24.9032万股,换手率0.82%,振幅5.13%。Fulgent Genetics, Inc.股票所在的生命科学行业中,整体跌幅为1.66%。Fulgent Genetics, Inc.公司简介:Fulgent Genetics Inc 是一家专注于基因检测的技术公司,为医生提供临床可操作的诊断信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716035232a6abc1a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716035232a6abc1a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","FLGT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fulgentgenetics.com","stockEarnings":[{"period":"1week","weight":-0.0614},{"period":"1month","weight":0.2369},{"period":"3month","weight":0.2893},{"period":"6month","weight":0.3206},{"period":"1year","weight":0.401},{"period":"ytd","weight":0.5322}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fulgent Genetics, Inc.在2016年5月13日注册成立于美国特拉华州。该公司是一家以技术为基础的公司,拥有成熟的临床诊断业务和治疗开发业务。该公司临床诊断业务提供分子诊断检测服务、全面的基因检测和高质量的解剖病理实验室服务,旨在为医生和患者提供临床可操作的诊断信息,以提高患者护理质量。该公司的治疗开发业务专注于使用新型纳米封装和靶向治疗平台开发治疗多种癌症的候选药物,该平台旨在改善新的和现有癌症药物的治疗窗口和药代动力学特征,或PK特征。该公司的目标是从基因组诊断业务转型为一家完全整合的精准医疗公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.120491},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.012384},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.021339},{"month":4,"riseRate":0.333333,"avgChangeRate":0.020112},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.000322},{"month":6,"riseRate":0.555556,"avgChangeRate":0.030965},{"month":7,"riseRate":0.666667,"avgChangeRate":0.112027},{"month":8,"riseRate":0.333333,"avgChangeRate":0.040364},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.027123},{"month":10,"riseRate":0.1,"avgChangeRate":-0.072376},{"month":11,"riseRate":0.6,"avgChangeRate":0.096806},{"month":12,"riseRate":0.7,"avgChangeRate":0.045576}],"exchange":"NASDAQ","name":"Fulgent Genetics Inc.","nameEN":"Fulgent Genetics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fulgent Genetics Inc.(FLGT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fulgent Genetics Inc.(FLGT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fulgent Genetics Inc.,FLGT,Fulgent Genetics Inc.股票,Fulgent Genetics Inc.股票老虎,Fulgent Genetics Inc.股票老虎国际,Fulgent Genetics Inc.行情,Fulgent Genetics Inc.股票行情,Fulgent Genetics Inc.股价,Fulgent Genetics Inc.股市,Fulgent Genetics Inc.股票价格,Fulgent Genetics Inc.股票交易,Fulgent Genetics Inc.股票购买,Fulgent Genetics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fulgent Genetics Inc.(FLGT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fulgent Genetics Inc.(FLGT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}